CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Enveric Biosciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Enveric Biosciences Inc
4851 Tamiami Trail N, Suite 200
Phone: (239) 302-1707p:239 302-1707 NAPLES, FL  34103  United States Ticker: ENVBENVB
Business Summary
Enveric Biosciences, Inc. is a biotechnology company. The Company is engaged in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. Leveraging its discovery and development platform, the Psybrary platform, which houses proprietary information on the use and development of existing and novel molecules for specific mental health indications, the Company seeks to develop a robust intellectual property portfolio of drug candidates. Its lead molecule, EB-003, is a neuroplastogen designed to promote neuroplasticity, without inducing hallucinations, in patients suffering from difficult-to-address mental health disorders. The Company is focused on advancing EB-003 towards clinical trials for the treatment of neuropsychiatric disorders while out-licensing other Psybrary platform drug candidates to third-party licensees and advancing non-competitive market strategies for patient care.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024YesYes--Yes

Industries
SIC Code Description
3674 Semiconductors and related devices
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Michael D.Webb 65 11/1/2022 6/13/2022
Chief Executive Officer, Director JosephTucker 55 9/16/2021 9/16/2021
Chief Financial Officer Kevin M.Coveney 60 3/13/2023 3/13/2023
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
MagicMed Industries, Inc. 3655 - 36 Street NW Calgary AB Canada
DC&M Partners, L.L.C. 2040 South Alma School Road Chandler AZ United States
Bellsoft, Inc. 3545 Cruse Road NW Lawrenceville GA United States

Business Names
Business Name
1236567 B.C. Unlimited Liability Company
1306432 B.C. Unlimited Liability Company
Akos Biosciences, Inc.
11 additional Business Names available in full report.

General Information
Number of Employees: 5 (As of 12/31/2024)
Outstanding Shares: 2,471,656 (As of 3/27/2025)
Shareholders: 183
Stock Exchange: NASD
Federal Tax Id: 954484725
Fax Number: (732) 243-9254
Email Address: info@spatializer.com


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025